Friday, June 19, 2026
🇺🇸 FDA

pharma · Metastatic Colorectal Cancer · Duchenne Muscular Dystrophy · SMMT

Summit Therapeutics

Summit Therapeutics trial registry — 46 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
601 Brickell Key Dr, Suite 1000, Miami, Florida 33131, US HQ
2003 Founded
367 Employees
Public company Type
SMMT · NYSE Ticker
Company details
Status
Public
HQ
601 Brickell Key Dr, Suite 1000, Miami, Florida 33131, US
Founded
2003
Employees
367
Programs
41
Drugs
32
Patents
20
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Summit Therapeutics clinical trials

Registry index of 46 ClinicalTrials.gov studies linked to Summit Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Summit Therapeutics trial registry — 46 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Summit Therapeutics.

  1. SMT112-3003 — Phase 3

    Clinical update

  2. SMT112-3005 — Phase 3

    Clinical update

  3. SMT112-3003 — Phase 3

    Clinical update

  4. ketamine — Phase 1

    Clinical update

  5. Hyperbaric Oxygen Therapy — Phase 2

    Clinical update

  6. SMT19969 — Phase 2

    Clinical update

  7. SMT C1100 — Phase 1

    Clinical update

  8. SMT C1100 — Phase 1

    Clinical update

Trial registry

46 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.